Lyncmed (Beijing) Biotech Co., Ltd.

Lyncmed (operating as LyncBio) is a high-tech medical enterprise headquartered in Beijing, China, specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) products and medical consumables. The company has established itself as a significant global supplier of rapid test kits, molecular diagnostic systems, and point-of-care testing (POCT) solutions. Lyncmed operates a large-scale manufacturing facility and maintains a robust international supply chain, providing products to over 100 countries. Their portfolio expanded significantly during the COVID-19 pandemic, where they became a key exporter of antigen and antibody tests. They are currently diversifying into oncology diagnostics, respiratory panels, and chronic disease management tools.